Anti-AKR7A2 antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | AKR7A2 |
| Immunogen: | This antibody is produced by immunizing mice with a synthetic peptide (KLH-coupled) corresponding to a region of AKR7A2. |
| Species immunized: | Mouse |
| Isotype: | IgG1 |
| Applications: | Western Blot (1:500-1:2000); Immunocytochemistry (1:100-1:200); Immunohistochemistry-Paraffin |
| Reactivity: | Zebrafish, Human |
| Clonality (clone number): | Monoclonal, C10-D5 |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 0.2% BSA, 40% glycerol, 0.05% NaN3. |
| Concentration: | 2 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | AFAR antibody |
| AFAR1 antibody | |
| AFB1 aldehyde reductase 1 antibody | |
| AFB1 AR1 antibody | |
| AFB1-AR 1 antibody | |
| AFB1AR1 antibody | |
| Aflatoxin aldehyde reductase antibody | |
| Aflatoxin B1 aldehyde reductase member 2 antibody | |
| Aflatoxin beta1 aldehyde reductase antibody | |
| Aiar antibody | |
| AKR7 antibody | |
| Akr7a2 antibody |
Show More
Target information
Catalyzes the NADPH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. May have an important role in producing the neuromodulator gamma-hydroxybutyrate (GHB). Has broad substrate specificity. Has NADPH-dependent aldehyde reductase activity towards 2-carboxybenzaldehyde, 2-nitrobenzaldehyde and pyridine-2-aldehyde (in vitro). Can reduce 1,2-naphthoquinone and 9,10-phenanthrenequinone (in vitro). Can reduce the dialdehyde protein-binding form of aflatoxin B1 (AFB1) to the non-binding AFB1 dialcohol. May be involved in protection of liver against the toxic and carcinogenic effects of AFB1, a potent hepatocarcinogen.
Provider
Erpantech Laboratory
